Radiotherapy after breast-conservation surgery: how much is enough?

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• National Surgical Adjuvant Breast Project (NSABP) trials provide crucial data on breast cancer treatment.
• Modified radical mastectomy was a standard treatment for early-stage invasive breast carcinoma.

Purpose of the Study:

• To evaluate breast conservation surgery (lumpectomy) combined with axillary dissection and irradiation.
• To compare survival outcomes of breast conservation therapy with modified radical mastectomy.
• To assess the impact of adjuvant therapies and specific irradiation fields on recurrence rates.

Main Methods:

• Analysis of NSABP clinical trial data for Stage I and II invasive breast carcinoma patients.
• Comparison of disease-free survival and overall survival rates between treatment groups.
• Evaluation of in-breast tumor recurrence incidence based on treatment modalities.

Main Results:

• Breast conservation surgery, axillary dissection, and irradiation yield survival rates equivalent to modified radical mastectomy.
• Breast irradiation post-lumpectomy significantly reduces in-breast tumor recurrence compared to lumpectomy alone.
• Adjuvant systemic therapy further decreases the incidence of in-breast tumor recurrence.

Conclusions:

• Breast conservation therapy is a viable alternative to mastectomy for early-stage breast cancer.
• Adjuvant systemic therapy and breast irradiation are beneficial in reducing recurrence.
• Irradiation of internal mammary, supraclavicular nodes, and axilla is not indicated for Stage I and II disease.